INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2017

Pomegranate supplementation did not significantly alter glucose or insulin measures in trials

A meta-analysis of 16 randomized controlled trials with 538 adult participants evaluated pomegranate supplementation. Pomegranate intake did not significantly alter fasting blood glucose (WMD -0.6 mg/dL, 95% CI: -2.79 to 1.58), fasting blood insulin (WMD 0.29 μIU/mL, 95% CI: -1.16 to 1.75), HOMA-IR, or HbA1c (WMD -0.11%, 95% CI: -0.39 to -0.18). The authors concluded pomegranate is not recommended for glycemic management.

Study type
Meta-analysis of randomized controlled trials
Who was studied
538 adults across 16 randomized controlled trials
What was measured
Fasting blood glucose, fasting insulin, HbA1c, and HOMA-IR

THE PAPER

Lack of efficacy of pomegranate supplementation for glucose management, insulin levels and sensitivity: evidence from a systematic review and meta-analysis.

Huang H, Liao D, Chen G, Chen H, Zhu Y. Nutr J, 2017.

PubMed 28985741 ↗DOI 10.1186/s12937-017-0290-1 ↗

Diabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.